SCHEMBL10242672

SCHEMBL10242672

CC(=O)c1ccc(-c2cc[nH]n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 2/20 0.49
ADORA3 P0DMS8 4/20 0.47
MAPT P10636 3/20 0.47
HSD17B1 P14061 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HPGD P15428 2/20 0.44
RAB9A P51151 1/20 0.44
MAOB P27338 1/20 0.41
LMNA P02545 2/20 0.41
BRD4 O60885 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
KMT2A Q03164 1/20 0.39
TP53 P04637 1/20 0.38
GAA P10253 1/20 0.38
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA2 P54646 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5836519 0.87 MAPT (0.53) ADORA3MAPTSMN1; SMN2HPGDRAB9A
SCHEMBL17303477 0.85 RXFP1 (0.44) MAPTHPGDRAB9ALMNAKMT2A
SCHEMBL1111577 0.83 KDM4E (0.47) SMN1; SMN2RAB9ATP53GAA
SCHEMBL182044 0.82 ALDH1A1 (0.55) MAPTSMN1; SMN2HPGDRAB9ALMNA
SCHEMBL28005157 0.81 METAP2 (0.32) XDHADORA3LMNAKMT2A
SCHEMBL3086806 0.81 MAPK1 (0.48) KMT2A
SCHEMBL4789775 0.81 ALDH1A1 (0.36) XDHADORA3MAPTRAB9ALMNA
Acetophenone SCHEMBL28143975 0.81 MAPT (0.41) XDHADORA3MAPTSMN1; SMN2HPGD
SCHEMBL12647574 0.81 MAP4K4 (0.50) BRD4KMT2A
Hydrochloric Acid SCHEMBL31747485 0.80 MAPK1 (0.47) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12024523-B2 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors ASTRAZENECA AB (SE) 2024-07-02 US disclosed
US-20230219967-A1 PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS ASTRAZENECA AB (SE) 2023-07-13 US disclosed
US-11691978-B2 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors ASTRAZENECA AB (SE) 2023-07-04 US disclosed
US-20210355127-A1 PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS ASTRAZENECA AB (SE) 2021-11-18 US disclosed
US-11001589-B2 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors ASTRAZENECA AB (SE) 2021-05-11 US disclosed
US-20200157113-A1 PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS ASTRAZENECA AB (SE) 2020-05-21 US disclosed
US-20190084991-A1 PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS ASTRAZENECA AB (SE) 2019-03-21 US disclosed
US-10183947-B2 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors ASTRAZENECA AB (SE) 2019-01-22 US disclosed
CN-103987775-B Rubber composition and pneumatic tire 住友橡胶工业株式会社 2016-06-22 CN disclosed
CN-102731722-B For the production of the method for modified conjugated diene polymer, modified conjugated diene polymer and polymer composition SUMITOMO CHEMICAL CO., LTD. (JP) 2016-03-16 CN disclosed
CN-102731722-A Process for producing modified conjugated diene-based polymer, modified conjugated diene-based polymer, and polymer composition SUMITOMO CHEMICAL CO 2012-10-17 CN disclosed
US-8148373-B2 Compounds ASTRAZENECA AB (SE) 2012-04-03 US disclosed
US-20090298807-A1 Compounds ASTRAZENECA AB (SE) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200157113-A1 PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS ALOX5, LIPG, ALOX15 XDH 101/4885ADORA3 2545/4885MAPT 4838/4885
US-20210355127-A1 PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS ALOX5, LIPG, ALOX15 XDH 101/4885ADORA3 2545/4885MAPT 4838/4885
US-10183947-B2 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors ALOX5, LIPG, ALOX15 XDH 101/4885ADORA3 2545/4885MAPT 4838/4885
US-11691978-B2 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors ALOX5, LIPG, ALOX15 XDH 101/4885ADORA3 2545/4885MAPT 4838/4885
US-20230219967-A1 PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS ALOX5, LIPG, ALOX15 XDH 101/4885ADORA3 2545/4885MAPT 4838/4885
US-20190084991-A1 PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS ALOX5, LIPG, ALOX15 XDH 101/4885ADORA3 2545/4885MAPT 4838/4885
US-12024523-B2 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors ALOX5, LIPG, ALOX15 XDH 101/4885ADORA3 2545/4885MAPT 4838/4885
US-11001589-B2 Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors ALOX5, LIPG, ALOX15 XDH 101/4885ADORA3 2545/4885MAPT 4838/4885
US-20090298807-A1 Compounds PKD1, SLC10A1, ABCB11 XDH 1239/4885ADORA3 1418/4885MAPT 3010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.